144 related articles for article (PubMed ID: 38899172)
1. Combined Rituximab and Daratumumab Treatment in Difficult-to-Treat Nephrotic Syndrome Cases.
Angeletti A; Bin S; Kajana X; Spinelli S; Bigatti C; Caridi G; Candiano G; Lugani F; Verrina EE; La Porta E; Magnasco A; Bruschi M; Cravedi P; Ghiggeri GM
Kidney Int Rep; 2024 Jun; 9(6):1892-1896. PubMed ID: 38899172
[No Abstract] [Full Text] [Related]
2. Review of the Role of Rituximab in the Management of Adult Minimal Change Disease and Immune-Mediated Focal and Segmental Glomerulosclerosis.
Aslam A; Koirala A
Glomerular Dis; 2023; 3(1):211-219. PubMed ID: 37901702
[TBL] [Abstract][Full Text] [Related]
3. New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are?
Basu B; Angeletti A; Islam B; Ghiggeri GM
Front Immunol; 2022; 13():805697. PubMed ID: 35222385
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis.
Angeletti A; Bin S; Magnasco A; Bruschi M; Cravedi P; Ghiggeri GM
Am J Transplant; 2024 Apr; 24(4):688-692. PubMed ID: 38101474
[TBL] [Abstract][Full Text] [Related]
5. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis.
Kronbichler A; Bruchfeld A
Nephron Clin Pract; 2014; 128(3-4):277-82. PubMed ID: 25401966
[TBL] [Abstract][Full Text] [Related]
6. Biologics in steroid resistant nephrotic syndrome in childhood: review and new hypothesis-driven treatment.
Angeletti A; Bruschi M; Kajana X; La Porta E; Spinelli S; Caridi G; Lugani F; Verrina EE; Ghiggeri GM
Front Immunol; 2023; 14():1213203. PubMed ID: 37705972
[TBL] [Abstract][Full Text] [Related]
7. Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
Gauckler P; Shin JI; Alberici F; Audard V; Bruchfeld A; Busch M; Cheung CK; Crnogorac M; Delbarba E; Eller K; Faguer S; Galesic K; Griffin S; Hrušková Z; Jeyabalan A; Karras A; King C; Kohli HS; Maas R; Mayer G; Moiseev S; Muto M; Odler B; Pepper RJ; Quintana LF; Radhakrishnan J; Ramachandran R; Salama AD; Segelmark M; Tesař V; Wetzels J; Willcocks L; Windpessl M; Zand L; Zonozi R; Kronbichler A;
Autoimmun Rev; 2020 Nov; 19(11):102671. PubMed ID: 32942039
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study.
Lan L; Lin Y; Yu B; Wang Y; Pan H; Wang H; Lou X; Lang X; Zhang Q; Jin L; Yang Y; Xiao L; Chen J; Han F
Am J Nephrol; 2024; 55(1):25-36. PubMed ID: 37963441
[TBL] [Abstract][Full Text] [Related]
9. Remission of steroid-resistant nephrotic syndrome due to focal and segmental glomerulosclerosis using rituximab.
Suri M; Tran K; Sharma AP; Filler G; Grimmer J
Int Urol Nephrol; 2008; 40(3):807-10. PubMed ID: 18491215
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies Targeting Nephrin in Podocytopathies.
Hengel FE; Dehde S; Lassé M; Zahner G; Seifert L; Schnarre A; Kretz O; Demir F; Pinnschmidt HO; Grahammer F; Lucas R; Mehner LM; Zimmermann T; Billing AM; Oh J; Mitrotti A; Pontrelli P; Debiec H; Dossier C; Colucci M; Emma F; Smoyer WE; Weins A; Schaefer F; Alachkar N; Diemert A; Hogan J; Hoxha E; Wiech T; Rinschen MM; Ronco P; Vivarelli M; Gesualdo L; Tomas NM; Huber TB;
N Engl J Med; 2024 May; ():. PubMed ID: 38804512
[TBL] [Abstract][Full Text] [Related]
11. Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis?
Kronbichler A; Mayer G
J Nephropathol; 2014 Jan; 3(1):1-3. PubMed ID: 24644535
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of adult-onset collapsing focal segmental glomerulosclerosis with rituximab.
Ramachandran R; Rajakumar V; Duseja R; Sakhuja V; Jha V
Clin Kidney J; 2013 Oct; 6(5):500-2. PubMed ID: 26120443
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.
Sinha A; Bhatia D; Gulati A; Rawat M; Dinda AK; Hari P; Bagga A
Nephrol Dial Transplant; 2015 Jan; 30(1):96-106. PubMed ID: 25121488
[TBL] [Abstract][Full Text] [Related]
14. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
Siligato R; Cernaro V; Nardi C; De Gregorio F; Gembillo G; Costantino G; Conti G; Buemi M; Santoro D
Expert Opin Investig Drugs; 2018 Nov; 27(11):839-879. PubMed ID: 30360670
[TBL] [Abstract][Full Text] [Related]
15. Adult-Onset Focal Segmental Glomerulosclerosis With Steroid-Dependent Nephrotic Syndrome Caused by a Novel TBC1D8B Variant: A Case Report and Literature Review.
Fang Z; Zhang C; Jin Y; Tong J; Liu J; Hao X; Weng Q; Yu S; Du W; Cai Y; Zheng Q; Yang L; Ren H; Pan X; Xie J
Am J Kidney Dis; 2023 Feb; 81(2):240-244. PubMed ID: 35970429
[TBL] [Abstract][Full Text] [Related]
16. Rituximab Therapy for Adults with Nephrotic Syndromes: Standard Schedules or B Cell-Targeted Therapy?
Del Vecchio L; Allinovi M; Rocco P; Brando B
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945143
[TBL] [Abstract][Full Text] [Related]
17. Rituximab therapy in nephrotic syndrome: implications for patients' management.
Sinha A; Bagga A
Nat Rev Nephrol; 2013 Mar; 9(3):154-69. PubMed ID: 23338210
[TBL] [Abstract][Full Text] [Related]
18. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
Peters HP; van de Kar NC; Wetzels JF
Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
[TBL] [Abstract][Full Text] [Related]
19. Nephrin Loss Can Be Used to Predict Remission and Long-term Renal Outcome in Patients With Minimal Change Disease.
van de Lest NA; Zandbergen M; IJpelaar DHT; Wolterbeek R; Bruijn JA; Bajema IM; Scharpfenecker M
Kidney Int Rep; 2018 Jan; 3(1):168-177. PubMed ID: 29340328
[TBL] [Abstract][Full Text] [Related]
20. Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.
Kronbichler A; König P; Busch M; Wolf G; Mayer G; Rudnicki M
Wien Klin Wochenschr; 2013 Jun; 125(11-12):328-33. PubMed ID: 23624956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
